Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
Critical Reviews™ in Eukaryotic Gene Expression
Facteur d'impact: 2.156 Facteur d'impact sur 5 ans: 2.255 SJR: 0.649 SNIP: 0.599 CiteScore™: 3

ISSN Imprimer: 1045-4403
ISSN En ligne: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2013007531
pages 275-282

Knockdown of ECHS1 Protein Expression Inhibits Hepatocellular Carcinoma Cell Proliferation via Suppression of Akt Activity

Chun Yao
Hospital
Yi-chen Dai
Department of Gastroenterology, the Chenggong Hospital Affiliated to Xiamen University, Wenyuan Road, Xiamen, Fujian 361003, China
Zhang-xing Chen
Department of Gastroenterology, the Chenggong Hospital Affiliated to Xiamen University, Wenyuan Road, Xiamen, Fujian 361003, China
Jun-pei Xie
Department of Gastroenterology, the Chenggong Hospital Affiliated to Xiamen University, Wenyuan Road, Xiamen, Fujian 361003, China
Wei Zeng
Department of Gastroenterology, the Chenggong Hospital Affiliated to Xiamen University, Wenyuan Road, Xiamen, Fujian 361003, China
Yuan-yuan Lin
Department of Gastroenterology, the Chenggong Hospital Affiliated to Xiamen University, Wenyuan Road, Xiamen, Fujian 361003, China
Qiu-hui Tan
Department of Gastroenterology, the Chenggong Hospital Affiliated to Xiamen University, Wenyuan Road, Xiamen, Fujian 361003, China

RÉSUMÉ

Overexpression of ECHS1 occurs in different cancers, including hepatocellular carcinoma (HCC). ECHS1 is also reported to have an oncogenic activity in various human cancers. This study investigated the effect of ECHS1 knockdown on the regulation of HCC growth. ECHS1 shRNA suppressed the expression of ECHS1 protein in HepG2 cells compared to the negative control vector-transfected HCC cells. ECHS1 knockdown also reduced HCC cell viability and enhanced cisplatin-induced apoptosis in HCC cells. Akt activation and the expression of various cell cycle-related genes were inhibited following ECHS1 knockdown. ECHS1 shRNA suppressed hepatocellular carcinoma growth in tumor xenograft mice. These data demonstrate that ECHS1 may play a role in HCC progression, suggesting that inhibition of ECHS1 expression using ECHS1 shRNA should be further evaluated as a novel target for the control of HCC.

MOTS CLÉS: ECHS1, HepG2 cells, PI3K/Akt

Articles with similar content:

Attenuation of Leukemia/Lymphoma-Related Factor Protein Expression Inhibits Glioma Cell Proliferation and Invasion
Journal of Environmental Pathology, Toxicology and Oncology, Vol.34, 2015, issue 2
Chun Yao, Tao Xie, Yin Zhao, Rui Huang
Evaluation of LncRNA ANRIL Potential in Hepatic Cancer Progression
Journal of Environmental Pathology, Toxicology and Oncology, Vol.38, 2019, issue 2
Yong Wang, Wanhua Ren, Zhaoyang Guo, Haiqing Liang, Hao Sun, Meili Lu, Yongjian Ji, Zhuozhen Lv
Effect of Hispolon from Phellinus lonicerinus (Agaricomycetes) on Estrogen Receptors, Aromatase, and Cyclooxygenase II in MCF-7 Breast Cancer Cells
International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 3
Fang Hu, Hongqi Zhang, Haili Yu, Beiyan Chen, Junzhi Wang, Xueling Zou, Wenfeng Huang, Jinyu Wang, Haibo He
miRNA: A Diagnostic and Therapeutic Tool for Pancreatic Cancer
Critical Reviews™ in Eukaryotic Gene Expression, Vol.27, 2017, issue 3
Muhammad Imran Qadir, Arooj Faheem
ALDOB Acts as a Novel HBsAg-Binding Protein and Its Coexistence Inhibits Cisplatin-Induced HepG2 Cell Apoptosis
Critical Reviews™ in Eukaryotic Gene Expression, Vol.24, 2014, issue 3
Can Dan, Yun-Peng Liu, Jian-Lin Ren, Chuan-Xing Xiao, Li-Juan Si, Jing Wu, Hong-Bo Zhao, Bayasi Guleng